Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,958 total articles
Nyxoah SA, a medical technology company specializing in solutions for Obstructive Sleep Apnea (OSA), has successfully closed an underwritten public offering raising approximately $95 million. The proceeds will be used to expand commercialization activities in the US and other markets, advance product development including Genio system upgrades, and…
Globus Maritime Limited reported Q1 2026 results showing a 42% increase in revenue to $12.2 million and adjusted EBITDA up to $6.2 million compared to Q1 2025. Time Charter Equivalent rates increased substantially, reflecting improved market conditions. Despite disruptions from hostilities in the Persian Gulf and resulting supply chain impacts, the…
Rumble Inc. announced its management team will engage in a series of upcoming investor conferences throughout June 2026, including virtual and in-person events. These include Maxim Group's AI Data Center Summit, the 16th Annual ROTH London Conference, and the Northland Growth Conference. The company aims to connect with institutional investors and …
Nasdaq held its 2026 Annual Meeting of Shareholders where all 12 nominated directors were elected for one-year terms, including the re-election of Adena T. Friedman as Chair of the Board. Shareholders also approved executive compensation on an advisory basis and ratified Ernst & Young LLP as the independent auditor for fiscal year 2026.
Cytek Biosciences, a Nasdaq-listed company specializing in advanced cell analysis solutions, announced its participation in the Singular Research's Las Vegas Invitational Conference from June 14-16, 2026. The company management will present on June 15th, with live and archived webcasts available. Cytek is known for its proprietary Full Spectrum Pro…
RadNet, a leading US outpatient diagnostic imaging services provider, secured a $250 million incremental term loan maturing in 2031, alongside a 0.25% interest rate reduction on its term loan and revolving credit facility. The proceeds will finance acquisitions, expansions, health system partnerships, and general corporate purposes, supporting RadN…
ZOOZ Strategy Ltd. announced that its Board of Directors has authorized management to explore a range of strategic alternatives that could complement its existing bitcoin treasury strategy, aiming to enhance long-term shareholder value. The review includes potential business combinations, acquisitions, partnerships, or capital initiatives but reaff…
Solidion Technology Inc. has successfully closed a $35 million private placement of common stock priced above market under Nasdaq rules. The proceeds fully fund the company through 2028, enabling accelerated commercialization of its patented Extreme-Climate Battery technology aimed at the Lunar economy, space applications, AI data center UPS system…
Oxford Industries announced its fiscal 2026 first quarter results with net sales nearly flat at $391 million compared to $393 million last year. Adjusted EPS declined due to increased tariff costs, softer sales at Lilly Pulitzer, and challenging market conditions. Tommy Bahama led growth with mid-single-digit gains, while Johnny Was and Lilly Pulit…
Humacyte, a Nasdaq-listed biotechnology company focused on bioengineered human tissues, has commenced an underwritten public offering of its common stock to raise funds for commercializing its FDA-approved product Symvess, filing a BLA supplement for hemodialysis, advancing pipeline product candidates, and for general corporate purposes. The offeri…
Celldex announced multiple presentations showcasing data from its mast cell-targeting therapies barzolvolimab and CDX-622 at the 2026 European Academy of Allergy and Clinical Immunology Annual Congress. Data includes Phase 1 results for CDX-622 and robust Phase 2 data on barzolvolimab in treating chronic spontaneous urticaria and cold urticaria, re…
Tectonic Therapeutic has completed enrollment for its 24-week APEX Phase 2 clinical trial evaluating the safety and efficacy of TX45 in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF). The trial enrolled 191 patients across 14 countries, focusing on those with the more severe combined p…
Concentrix Corporation, a Fortune 500 technology and services company specializing in integrated human and AI solutions, will release its fiscal second quarter 2026 financial results after market close on June 29, 2026. The company will also hold a conference call and webcast to discuss results on the same day.
Humacyte announced positive interim results from its V012 Phase 3 study showing that its acellular tissue engineered vessel (ATEV) provides significantly more catheter-free days compared to the current standard of care, autologous AV fistula, in female dialysis patients. The trial met its primary endpoint with a strong statistical significance, lea…
Asure Software, listed on Nasdaq as ASUR, is highlighting its ongoing investment in small and mid-sized business (SMB) payroll and HR solutions at the SHRM 2026 conference. The company emphasizes its innovative technology platform and managed services aimed at helping SMBs address workforce complexity, compliance requirements, and administrative ch…
Exicure, Inc. disclosed a Nasdaq notification indicating it failed to meet the minimum stockholders' equity requirement of $2.5 million, reporting approximately $2.1 million. The company attributes this shortfall partly to prior executive separation expenses and legacy consulting costs. Though the stock remains listed, Exicure has 45 days to submit…
IDT Corporation, a fintech and communications provider listed on NYSE as IDT, announced it will present its business overview, strategy, and financial results for fiscal 2026 Q3 at the East Coast IDEAS Investor Conference on June 11, 2026. The presentation, led by CFO Marcelo Fischer and VP of Investor Relations Bill Ulrey, will be webcast and incl…
Cosmos Health Inc., a US-listed global healthcare group, announced that its subsidiary Cana Laboratories secured a three-year contract manufacturing agreement with specialty pharmaceutical company Verisfield S.A. Cana will produce 1.3 million units annually of VASCLOR GEST progesterone vaginal pessaries, used in assisted reproduction treatments. Th…
Xcel Brands announces a strategic partnership with Baggallini and fashion icon Coco Rocha to release a limited-edition capsule collection. The collection centers on the 'Super Bagg,' an oversized, multifunctional handbag that blends style and organization for modern women. Launching publicly on September 17, 2025, the collection aims to meet the ne…
NOVAGOLD Resources Inc. will release its 2026 Q2 financial report on June 24, 2026, followed by a conference call and video webcast to discuss the results. Company executives will provide updates on financial performance, Donlin Gold feasibility study progress, community engagement, and environmental efforts.
Visionary Holdings Inc. received a formal determination from Nasdaq to delist its securities after failing to timely file required financial reports. The company has not submitted a compliance restoration plan within the allotted period, prompting Nasdaq to initiate delisting procedures. Visionary Holdings intends to request a hearing to appeal the…
Btab Ecommerce Group announced its Strategic Alliance Initiative to expand its AI-powered commerce strategy by activating over 300,000 small and medium businesses globally as product-selling partners in its owned ecommerce ecosystem. This model offers partners AI-driven storefronts, supply chain, and fulfillment services without upfront investment,…
Genco Shipping & Trading Limited is urging shareholders to vote in favor of its current highly qualified board directors and reject the nominees put forth by Diana Shipping Inc. The company highlights its board's experience and track record of delivering superior returns through its Comprehensive Value Strategy. Proxy advisory firms ISS, Glass Lewi…
Teva Pharmaceutical Industries Ltd. announced the closing of its acquisition of Emalex Biosciences for $700 million, with potential milestone payments of up to $200 million, strengthening its late-stage neuroscience pipeline. The acquisition brings ecopipam, a first-in-class dopamine D1 receptor antagonist for pediatric Tourette syndrome, which rec…
Wix.com Ltd. announced its integration with Stripe Projects' command-line interface (CLI), allowing developers and AI agents to provision a complete Wix business backend effortlessly through Stripe Projects. This integration streamlines the process from business idea to live, revenue-ready operation, consolidating commerce, CMS, CRM, bookings, even…
